Full Text View
Tabular View
No Study Results Posted
Related Studies
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
This study is currently recruiting participants.
Verified by University Hospital, Strasbourg, France, January 2009
First Received: September 13, 2005   Last Updated: January 9, 2009   History of Changes
Sponsored by: University Hospital, Strasbourg, France
Information provided by: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT00213798
  Purpose

The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.


Condition Intervention
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Procedure: Biopsy samples

MedlinePlus related topics: Cancer Lung Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Screening, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title: Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.

Further study details as provided by University Hospital, Strasbourg, France:

Estimated Enrollment: 200
Study Start Date: December 2003
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
  • No lung instability.
  • Individuals give all informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00213798

Contacts
Contact: Michèle Beau-Faller, MD michele.faller@chru-strasbourg.fr

Locations
France
Service de Pneumologie, Hôpital de Hautepierre Recruiting
STRASBOURG, France, 67098
Contact: Michèle BEAU-FALLER, MD     33.3.88.12.71.79     Michele.Faller@chru-strasbourg.fr    
Principal Investigator: Michèle BEAU-FALLER, MD            
Sub-Investigator: Romain KESSLER, MD            
Sub-Investigator: Emmanuel WEITZENBLUM, MD            
Service de Pneumologie, Hôpital Civil Recruiting
STRASBOURG, France, 67091
Contact: Gabrielle PAULI, MD     33.3.88.11.62.23     Gabrielle.Pauli@chru-strasbourg.fr    
Sub-Investigator: Elisabeth QUOIX, MD            
Sub-Investigator: Gabrielle PAULI, MD            
Principal Investigator: Michèle Beau-Faller, MD            
Service de Chirurgie Thoracique, Hôpital Civil Recruiting
Strasbourg, France, 67091
Contact: Michèle Beau-Faller, MD         michele.faller@chru-strasbourg.fr    
Sub-Investigator: Jean-Marie WIHLM, MD            
Sub-Investigator: Gilbert MASSARD, MD            
Sub-Investigator: Xavier-Pierre DUCROCQ, MD            
Sub-Investigator: Valérie HAMMERER, MD            
Sub-Investigator: Carine METZ FAVRE, MD            
Sub-Investigator: Mircea-Dan VASILESCU, MD            
Service de Pneumologie, Hôpital Lyautey Recruiting
Strasbourg, France, 67000
Contact: Michèle Beau-Faller, MD         michele.faller@chru-strasbourg.fr    
Sub-Investigator: Anita DIETEMANN, MD            
Sub-Investigator: Bertrand MENNECIER, MD            
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Principal Investigator: Michèle BEAU-FALLER, MD Service de Pneumologie, Hôpital de Hautepierre
  More Information

No publications provided

Responsible Party: University Hospital, Strasbourg, France ( Emmanuel LAVOUE, Directeur Adjoint )
Study ID Numbers: 2731
Study First Received: September 13, 2005
Last Updated: January 9, 2009
ClinicalTrials.gov Identifier: NCT00213798     History of Changes
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Strasbourg, France:
Lung cancer
plasma DNA
allelotyping
follow-up
Prospective Study
Non-Small Cell Lung Cancer
Small Cell Lung Cancer

Study placed in the following topic categories:
Thoracic Neoplasms
Carcinoma, Neuroendocrine
Carcinoma
Neuroendocrine Tumors
Carcinoma, Small Cell
Neuroectodermal Tumors
Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases
Neoplasms, Germ Cell and Embryonal
Neuroepithelioma
Non-small Cell Lung Cancer
Adenocarcinoma
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:
Thoracic Neoplasms
Respiratory Tract Neoplasms
Neoplasms by Histologic Type
Carcinoma, Neuroendocrine
Neoplasms, Nerve Tissue
Neuroendocrine Tumors
Carcinoma
Carcinoma, Small Cell
Neuroectodermal Tumors
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Lung Neoplasms
Neoplasms, Germ Cell and Embryonal
Lung Diseases
Adenocarcinoma
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on May 07, 2009